Cite

HARVARD Citation

    Keil, R. et al. (2016). Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis. Scandinavian journal of gastroenterology. pp. 1062-1068. [Online]. 
  
Back to record